During tough times, it is natural for many of us to look for charitable opportunities to help our community. However, the COVID-19 situation displays challenges we have not had to Continue Reading
Phenomenex and their parent company, Danaher, have jumped into action as the 2019-nCoV, or as the media has dubbed it – the coronavirus, has spread throughout China, affecting many associates Continue Reading
Learn about Phenomenex’s 2018 International Philanthropy Efforts Philanthropy is a huge part of Phenomenex culture, and 2018 didn’t disappoint. Our teams around the world held several events and fundraisers to Continue Reading
Phenomenex Philanthropy Partners with the Do Good Bus On October 10th, 2018, a group of Phenomenex volunteers gathered together and boarded a retro style school bus, dubbed the Do Good Continue Reading
The Phenomenex UK team got together and spent two exceptionally fulfilling days working with The Rossendale Trust, an organization that provides supported living care to adults with learning and physical Continue Reading
A social media sensation has finally paid off. The U.S. Food and Drug Administration (FDA) has recently approved the first drug to combat amyotrophic lateral sclerosis, or ALS, in 22 years. Continue Reading
One might expect the CEO of a global separation sciences company to be a chemistry graduate, with in-depth training in analytical chemistry. In fact, Persian-born Fasha Mahjoor, the charismatic CEO of Phenomenex, failed all of the chemistry exams at his English boarding school before going on to acquire a Masters in architecture.
The Humanity in Science Award was created in 2015 to recognize outstanding developments in science that could change human lives for the better.